INCY logo

Combined Holdings of INCY in All ARK ETFs

Incyte Corporation

Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of proprietary therapeutics, primarily in oncology. The company generates revenue through the sale of its pharmaceutical products, such as Jakafi (ruxolitinib), as well as through collaborations and royalty agreements with other pharmaceutical companies.

Trades of INCY in All Ark ETFs

The ten most recent trades of Incyte Corporation in all the Ark ETFs ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Nov 06, 2024Sell$1,952,62913.10%0.16%
Jul 12, 2024Sell$1,361,38110.38%0.10%
Jul 10, 2024Sell$3,752,11623.07%0.30%
Jul 09, 2024Sell$3,072,89816.08%0.25%
Jul 08, 2024Sell$1,614,4607.99%0.13%
Jul 05, 2024Sell$518,4872.53%0.04%
Apr 09, 2024Sell$556,7432.41%0.04%
Apr 08, 2024Sell$794,2533.34%0.05%
Apr 08, 2024Sell$794,2533.34%0.05%
Apr 08, 2024Sell$794,2533.34%0.05%